Ticker
CPIXCompany Name
CUMBERLAND PHARMACEUTICALS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Capital Expenditure | Capital Expenditures to Operating Cash Flow | Net Cash Flow - Operations |
---|---|---|---|
6/30/2025 | $ 1.02M | 14.28% | $ 7.12M |
3/31/2025 | $ 1.35M | 24.89% | $ 5.42M |
12/31/2024 | $ 179.71K | 0% | $ -612.19K |
9/30/2024 | $ 239.62K | 0% | $ -1.48M |
6/30/2024 | $ 286.78K | 0% | $ -715.64K |
3/31/2024 | $ 336.78K | 6.27% | $ 5.38M |
12/31/2023 | $ 453.05K | 7.43% | $ 6.09M |
9/30/2023 | $ 2.01M | 23.09% | $ 8.69M |
6/30/2023 | $ 2.13M | 21.11% | $ 10.09M |
3/31/2023 | $ 2.21M | 30.71% | $ 7.19M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx / CF - Operations
(=) CapEx/OCF
CapEx/OCF for CUMBERLAND PHARMACEUTICALS INC is calculated as follows: CapEx [ $ 2.26M ] / CF - Operations [ $ 5.42M ]
(=) CapEx/OCF [ 41.66% ]
Minimum
Dec 31, 2021
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 2.35K |
---|---|
min | 0.01% |
max | 128% |
average | 31.81% |
median | 22.42% |
std | 29.51% |